Search Results

There are 4539 results for: content related to: Experimental therapeutics for patients with myeloproliferative neoplasias

  1. You have free access to this content
    JAK2 and genomic instability in the myeloproliferative neoplasms: A case of the chicken or the egg?

    American Journal of Hematology

    Volume 87, Issue 11, November 2012, Pages: 1028–1036, Linda M. Scott and Vivienne I. Rebel

    Article first published online : 28 MAY 2012, DOI: 10.1002/ajh.23243

  2. You have free access to this content
    The JAK2 exon 12 mutations: A comprehensive review

    American Journal of Hematology

    Volume 86, Issue 8, August 2011, Pages: 668–676, Linda M. Scott

    Article first published online : 14 JUN 2011, DOI: 10.1002/ajh.22063

  3. You have free access to this content
    MicroRNAs in myeloproliferative neoplasms

    British Journal of Haematology

    Volume 161, Issue 4, May 2013, Pages: 471–483, Huichun Zhan, Christopher Cardozo and Azra Raza

    Article first published online : 25 FEB 2013, DOI: 10.1111/bjh.12276

  4. You have free access to this content
    Occurrence of the JAK2 V617F mutation in patients with peripheral arterial disease

    American Journal of Hematology

    Volume 90, Issue 1, January 2015, Pages: E17–E21, Axel Muendlein, Elena Kinz, Klaus Gasser, Andreas Leiherer, Philipp Rein, Christoph H. Saely, Harald Grallert, Annette Peters, Peter Fraunberger, Heinz Drexel and Alois H. Lang

    Article first published online : 20 NOV 2014, DOI: 10.1002/ajh.23874

  5. JAK2 46/1 haplotype is associated with JAK2 V617F – positive myeloproliferative neoplasms in Brazilian patients

    International Journal of Laboratory Hematology

    L. C. Macedo, B. C. Santos, S. Pagliarini-e-Silva, K. B. B. Pagnano, C. Rodrigues, F. C. Quintero, M. E. Ferreira, E. C. Baraldi, E. P. Ambrosio-Albuquerque, A. M. Sell and J. E. L. Visentainer

    Article first published online : 11 MAY 2015, DOI: 10.1111/ijlh.12380

  6. You have free access to this content
    Evaluation of the prevalence and prospective clinical impact of the JAK2 V617F mutation in coronary patients

    American Journal of Hematology

    Volume 89, Issue 3, March 2014, Pages: 295–301, Axel Muendlein, Klaus Gasser, Elena Kinz, Nicole Stark, Andreas Leiherer, Philipp Rein, Christoph H. Saely, Harald Grallert, Annette Peters, Heinz Drexel and Alois H. Lang

    Article first published online : 18 FEB 2014, DOI: 10.1002/ajh.23632

  7. You have free access to this content
    Modulation of JAK2 V617F allele burden dynamics by hydroxycarbamide in polycythaemia vera and essential thrombocythaemia patients

    British Journal of Haematology

    Volume 152, Issue 4, February 2011, Pages: 413–419, Carlos Besses, Alberto Álvarez-Larrán, Luz Martínez-Avilés, Sergi Mojal, Raquel Longarón, Antonio Salar, Lourdes Florensa, Sergi Serrano and Beatriz Bellosillo

    Article first published online : 10 JAN 2011, DOI: 10.1111/j.1365-2141.2010.08467.x

  8. You have free access to this content
    The JAK2V617F mutation and thrombosis

    British Journal of Haematology

    Volume 143, Issue 3, November 2008, Pages: 307–320, S. K. Austin and J. R. Lambert

    Article first published online : 30 MAY 2008, DOI: 10.1111/j.1365-2141.2008.07258.x

  9. Real-Time PCR and Droplet Digital PCR: two techniques for detection of the JAK2V617F mutation in Philadelphia-negative chronic myeloproliferative neoplasms

    International Journal of Laboratory Hematology

    G. Fontanelli, C. Baratè, E. Ciabatti, F. Guerrini, S. Grassi, M. Del Re, R. Morganti, I. Petrini, R. Arici, S. Barsotti, M. R. Metelli, R. Danesi and S. Galimberti

    Article first published online : 20 JUL 2015, DOI: 10.1111/ijlh.12404

  10. You have free access to this content
    JAK2-V617F mutation analysis of granulocytes and platelets from patients with chronic myeloproliferative disorders: advantage of studying platelets

    British Journal of Haematology

    Volume 139, Issue 1, October 2007, Pages: 64–69, Kohtaro Toyama, Masamitsu Karasawa, Arito Yamane, Hiroyuki Irisawa, Akihiko Yokohama, Takayuki Saitoh, Hiroshi Handa, Takafumi Matsushima, Morio Sawamura, Shuichi Miyawaki, Hirokazu Murakami, Yoshihisa Nojima and Norifumi Tsukamoto

    Article first published online : 11 SEP 2007, DOI: 10.1111/j.1365-2141.2007.06755.x

  11. You have free access to this content
    Spleen deflation and beyond: The pros and cons of Janus kinase 2 inhibitor therapy for patients with myeloproliferative neoplasms

    Cancer

    Volume 118, Issue 4, 15 February 2012, Pages: 870–877, Alfonso Quintás-Cardama and Srdan Verstovsek

    Article first published online : 15 JUL 2011, DOI: 10.1002/cncr.26359

  12. You have full text access to this Open Access content
    The JAK kinase inhibitor CP-690,550 supresses the growth of human polycythemia vera cells carrying the JAK2V617F mutation

    Cancer Science

    Volume 99, Issue 6, June 2008, Pages: 1265–1273, Taghi Manshouri, Alfonso Quintás-Cardama, Roberto H. Nussenzveig, Amos Gaikwad, Zeev Estrov, Josef Prchal, Jorge E. Cortes, Hagop M. Kantarjian and Srdan Verstovsek

    Article first published online : 28 JUN 2008, DOI: 10.1111/j.1349-7006.2008.00817.x

  13. You have free access to this content
    JAK2V617F monitoring in polycythemia vera and essential thrombocythemia: Clinical usefulness for predicting myelofibrotic transformation and thrombotic events

    American Journal of Hematology

    Volume 89, Issue 5, May 2014, Pages: 517–523, Alberto Alvarez-Larrán, Beatriz Bellosillo, Arturo Pereira, Ana Kerguelen, Juan Carlos Hernández-Boluda, Luz Martínez-Avilés, Concepción Fernández-Rodríguez, Montse Gómez, Luis Lombardía, Anna Angona, Águeda Ancochea, Alicia Senín, Raquel Longarón, Blanca Navarro, María Collado and Carlos Besses

    Article first published online : 21 FEB 2014, DOI: 10.1002/ajh.23676

  14. You have free access to this content
    JAK2-V617F-mediated signalling is dependent on lipid rafts and statins inhibit JAK2-V617F-dependent cell growth

    British Journal of Haematology

    Volume 160, Issue 2, January 2013, Pages: 177–187, Lori N. Griner, Kathy L. McGraw, Joseph O. Johnson, Alan F. List and Gary W. Reuther

    Article first published online : 15 NOV 2012, DOI: 10.1111/bjh.12103

  15. You have full text access to this Open Access content
    Molecular drug targets in myeloproliferative neoplasms: mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1

    Journal of Cellular and Molecular Medicine

    Volume 13, Issue 2, February 2009, Pages: 215–237, Ayalew Tefferi

    Article first published online : 23 OCT 2008, DOI: 10.1111/j.1582-4934.2008.00559.x

  16. You have free access to this content
    The JAK2V617F tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates

    British Journal of Haematology

    Volume 131, Issue 3, November 2005, Pages: 320–328, Ayalew Tefferi, Terra L. Lasho, Susan M. Schwager, David P. Steensma, Ruben A. Mesa, Chin-Yang Li, Martha Wadleigh and D. Gary Gilliland

    Article first published online : 26 SEP 2005, DOI: 10.1111/j.1365-2141.2005.05776.x

  17. You have free access to this content
    Phospho-STAT5 and phospho-Akt expression in chronic myeloproliferative neoplasms

    British Journal of Haematology

    Volume 147, Issue 4, November 2009, Pages: 495–506, Lizz F. Grimwade, Lisa Happerfield, Colin Tristram, Gary McIntosh, Mark Rees, Anthony J. Bench, Elaine M. Boyd, Marie Hall, Amy Quinn, Nigel Piggott, Paul Scorer, Mike A. Scott and Wendy N. Erber

    Article first published online : 31 AUG 2009, DOI: 10.1111/j.1365-2141.2009.07870.x

  18. Dysregulation of the MIRLET7/HMGA2 axis with methylation of the CDKN2A promoter in myeloproliferative neoplasms

    British Journal of Haematology

    Volume 168, Issue 3, February 2015, Pages: 338–349, Kayo Harada-Shirado, Kazuhiko Ikeda, Kazuei Ogawa, Hiroshi Ohkawara, Hideo Kimura, Tatsuyuki Kai, Hideyoshi Noji, Soji Morishita, Norio Komatsu and Yasuchika Takeishi

    Article first published online : 19 SEP 2014, DOI: 10.1111/bjh.13129

  19. You have free access to this content
    De novo childhood myelodysplastic/myeloproliferative disease with unique molecular characteristics

    British Journal of Haematology

    Volume 158, Issue 1, July 2012, Pages: 129–137, Olfat Ismael, Akira Shimada, Asahito Hama, Momen Elshazley, Hideki Muramatsu, Aya Goto, Hirotoshi Sakaguchi, Makito Tanaka, Yoshiyuki Takahashi, Xu Yinyan, Minoru Fukuda, Yuji Miyajima, Yuka Yamashita, Keizo Horibe, Ryoji Hanada, Masafumi Ito and Seiji Kojima

    Article first published online : 10 MAY 2012, DOI: 10.1111/j.1365-2141.2012.09140.x

  20. Mutations profile of polycythemia vera and essential thrombocythemia among Japanese children

    Pediatric Blood & Cancer

    Volume 59, Issue 3, September 2012, Pages: 530–535, Olfat Ismael, Akira Shimada, Asahito Hama, Hiroshi Sakaguchi, Sayoko Doisaki, Hideki Muramatsu, Nao Yoshida, Masafumi Ito, Yoshiyuki Takahashi, Naohiro Akita, Shosuke Sunami, Yoshitoshi Ohtsuka, Youji Asada, Hiroyuki Fujisaki and Seiji Kojima

    Article first published online : 21 NOV 2011, DOI: 10.1002/pbc.23409